Shoreline Biosciences secured $140 million in financing to accelerate the growth of its induced pluripotent stem cells (iPSC)-based immunotherapies and support the expansion of its manufacturing capabilities. The financing round comes hot off the heels of two partnerships the company struck this summer valued at $4 billion. Shoreline entered into collaborations with Kite Pharmaceuticals, a Gilead Sciences company, and BeiGene. […]

Shoreline Biosciences’ work developing “off-the-shelf” cell therapies for cancer has led to strategic partnerships with BeiGene and Gilead Sciences. Now those pharmaceutical companies are joining a $140 million investment in the biotech, which will use the cash for the manufacturing and preclinical development of its cell immunotherapies. The financing announced Tuesday comes seven months after Shoreline unveiled […]

OKLAHOMA CITY (KFOR) – An Oklahoma City charter school has become the first in the state to enroll in a free federal COVID-19 testing program. Operation Expanded Testing is a $650 million initiative by the Biden Administration and Department of Health and Human Services. It’s designed to give schools as well as community organizations the […]